Wyant Alyssa 4
4 · Edge Therapeutics, Inc. · Filed Mar 5, 2018
Insider Transaction Report
Form 4
Wyant Alyssa
SVP Regulatory Affairs
Transactions
- Award
Stock Option (Right To Purchase)
2018-03-01+50,000→ 50,000 totalExercise: $14.98Exp: 2028-03-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 50,000 shares of Common Stock, will become exercisable on March 1, 2019, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.